HU0300988D0 - Combination containing antagonist of vanilloid receptor - Google Patents

Combination containing antagonist of vanilloid receptor

Info

Publication number
HU0300988D0
HU0300988D0 HU0300988A HUP0300988A HU0300988D0 HU 0300988 D0 HU0300988 D0 HU 0300988D0 HU 0300988 A HU0300988 A HU 0300988A HU P0300988 A HUP0300988 A HU P0300988A HU 0300988 D0 HU0300988 D0 HU 0300988D0
Authority
HU
Hungary
Prior art keywords
combination containing
vanilloid receptor
containing antagonist
antagonist
vanilloid
Prior art date
Application number
HU0300988A
Other languages
Hungarian (hu)
Original Assignee
Synosens Kutato Es Fejlesztoe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synosens Kutato Es Fejlesztoe filed Critical Synosens Kutato Es Fejlesztoe
Priority to HU0300988A priority Critical patent/HU0300988D0/en
Publication of HU0300988D0 publication Critical patent/HU0300988D0/en

Links

HU0300988A 2003-04-15 2003-04-15 Combination containing antagonist of vanilloid receptor HU0300988D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU0300988A HU0300988D0 (en) 2003-04-15 2003-04-15 Combination containing antagonist of vanilloid receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0300988A HU0300988D0 (en) 2003-04-15 2003-04-15 Combination containing antagonist of vanilloid receptor

Publications (1)

Publication Number Publication Date
HU0300988D0 true HU0300988D0 (en) 2003-06-28

Family

ID=89981305

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300988A HU0300988D0 (en) 2003-04-15 2003-04-15 Combination containing antagonist of vanilloid receptor

Country Status (1)

Country Link
HU (1) HU0300988D0 (en)

Similar Documents

Publication Publication Date Title
EP1868985A4 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
PL376057A1 (en) Diaryl ethers as opioid receptor antagonist
HK1090922A1 (en) Cgrp receptor antagonists cgrp
IL169575A0 (en) Calcium-sensing receptor antagonist compounds and pharmaceutical compositions containing the same
IL176069A0 (en) Cbi antagonist compounds
EP1656378A4 (en) Compounds and compositions as inhibitors of receptor tyrosine kinase activity
HK1085400A1 (en) Quinazoline analogs as receptor tyrosine kinase inhibitors
IS8119A (en) Dense N-heterocyclic compounds and their use as CRF receptor antagonists
HK1079451A1 (en) Use of compounds that are effective as selective opiate receptor modulators
EP1758458A4 (en) Compositions containing opioid antagonists
EP1641781A4 (en) Benzodiazepine cgrp receptor antagonists
PL378576A1 (en) Preparation of substituted quinazolines
EP1572103A4 (en) Anti-angiogenic uses of il-6 antagonists
EP1806147A4 (en) Use of immunesuppressant receptor
IL158701A0 (en) Novel use of nk3 receptor antagonist
PL378753A1 (en) Ccr-3 receptor antagonists
AU2003260072A8 (en) Antagonists of chemokine receptors
SI1660090T1 (en) Quinazoline analogs as receptor tyrosine kinase inhibitors
IL165599A0 (en) Compositions containing an alpha adrenergic receptor antagonist
SG131946A1 (en) Ccr3 receptor antagonists
HU0300988D0 (en) Combination containing antagonist of vanilloid receptor
EP1651643A4 (en) Bicyclic compounds and compositions as pdf inhibitors
HK1085926A1 (en) Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis
PL368843A1 (en) Medicinal compositions containing angiotensin ii receptor antagonist
HU0400845D0 (en) Pharmaceutical composition containing vanilloid receptor antagonist